Duke biotech spinout hikes funding round to $89M


Despite an uneasy market for biotech funding, a Duke University spinout is adding another $19 million to its coffers after completing a large raise last year.

Previous $352 million acquisition of Sezzle called off as buy now, pay later market sours
Next Hannon Armstrong shares drop amid accusations of inflated earnings